Saturday, April 3, 2021

Rossari Biotech IPO: A diversified portfolio, expansion are key triggers

The expansion is expected to support growth with revenues and profits estimated to rise by 20-25 per cent over the FY20-23 period

from Today's Paper https://ift.tt/2PlNNtn
via

No comments:

Post a Comment

If you have any doubts please let me know!

India's low score on GVC a starting point for recovery from pandemic: AIIB

India rated 7.4 percentage points below the average global value chain participation rate for emerging economies from Today's Paper ht...